Korea Investment CORP Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Korea Investment CORP decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 190,925 shares of the company's stock after selling 25,663 shares during the quarter. Korea Investment CORP owned about 0.08% of HCA Healthcare worth $57,306,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of HCA. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $840,000. Woodmont Investment Counsel LLC increased its stake in HCA Healthcare by 3.8% during the 4th quarter. Woodmont Investment Counsel LLC now owns 58,724 shares of the company's stock valued at $17,626,000 after purchasing an additional 2,168 shares in the last quarter. Congress Wealth Management LLC DE lifted its stake in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares in the last quarter. LPL Financial LLC raised its holdings in shares of HCA Healthcare by 21.2% in the 4th quarter. LPL Financial LLC now owns 61,581 shares of the company's stock worth $18,484,000 after acquiring an additional 10,777 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in HCA Healthcare during the 4th quarter valued at about $20,091,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Remove Ads

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $0.31 during mid-day trading on Tuesday, hitting $345.86. The company had a trading volume of 1,226,315 shares, compared to its average volume of 1,348,308. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock's 50-day moving average price is $325.79 and its 200-day moving average price is $340.25. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $85.15 billion, a price-to-earnings ratio of 15.74, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company earned $5.90 earnings per share. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on HCA shares. Truist Financial cut their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. KeyCorp lowered their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.